VAERS reports by lot

GSK Varicella/Shingles lot HG4P3: VAERS reports

126 VAERS reports list lot HG4P3 as a GSK Varicella/Shingles vaccine, received between 2018-04-12 and 2021-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
126
Reports
6%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction14131%
General / Systemic (non-local)10523%
Dermatological (non-injection-site)4811%
Neurological409%
Musculoskeletal388%
Allergic / Anaphylactic347%
Gastrointestinal327%
Cardiac / Cardiovascular92%
Psychiatric / Neuropsychiatric61%
Respiratory20%
Autoimmune / Immune-mediated10%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York18
California13
Pennsylvania7
Texas7
Virginia6
Massachusetts5
Connecticut5
Vermont4
Washington4
Minnesota4
Maryland4
North Carolina3

Reports by month received

2018-0418
2018-0552
2018-0623
2018-078
2018-0810
2018-093
2018-103
2018-111
2018-121
2019-011
2019-042
2020-031
2020-072
2021-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.